The Gut Microbiota of Bipolar and Depression

NCT ID: NCT03062332

Last Updated: 2021-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

240 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-16

Study Completion Date

2022-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: The gut microbiome is emerging as an important factor in regulating mental health yet it remains unclear what the target should be for psychiatric treatment. Investigators aim at elucidating the complement of the gut microbiome community for individuals with Major Depressive disorder (MDD) and Bipolar disorder (BD) relative to controls, and test for relationships with symptoms.

Methods: Investigators prospect to recruit subjects including patients and controls amount to 240. All subjects will be collected for blood and stool samples,assessed by clinical scales. Finally, analyzing the correlation among the metabolon in blood, microbiota in stool and clinical scales to obtain the possible interaction between diseases and gut microbiota.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: MDD (Major Depressive disorder) and BD (Bipolar disorder), whose specific pathogenesis is still unclear, are both a multi-factorial disease being caused by biological, psychological and social factors. Accumulating evidence suggests that gut microbiota play an important role in brain functions and in the pathogenesis of neuropsychiatric diseases, such as autism, anxiety, as well as depression. No study has thus far compared the human gut microbiota among BD, MDD and the healthy control (HC). The aim of this study is to compare the composition of fecal microbiota among BD, MDD and HC. Furthermore, investigators aim at identifying direct correlations between human fecal microbiota (as a proxy for gut microbiota) and symptoms.

Methods:

1. Investigators aim at recruiting human subjects in total 240, which including mania episode of bipolar disorder (40), depressive episode of bipolar disorder (40), mixed episode of bipolar disorder (40), first episode of major depressive disorder (40), recurrent episode of major depressive disorder (40), and healthy control (40). All patients, diagnosed according to the research criteria of the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10), come from The First Affiliated Hospital of Xi'an Jiaotong University and controls are healthy volunteers.
2. Collecting blood and stool samples, evaluating clinical scales including Montgomery-Asberg Depression Scale (MADRS), Young Mania Rating Scale (YMRS), Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Measurement And Treatment Research To Improve Cognition In Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB), Clinical Global Impression (CGI) are all finished in first day after threshold.
3. Measure the metabolon in blood such as S-CFA, and gut microbiota.
4. Using Statistical Program for Social Sciences (SPSS) to compare general and clinical data among groups and analyze the correlation between the microbiota and symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder Major Depressive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bipolar disorder,mania

The group includes subjects who are diagnosed to mania episode of bipolar disorder.

Faecal genome

Intervention Type GENETIC

Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.

Bipolar disorder,depressive

The group includes subjects who are diagnosed to depression episode of bipolar disorder.

Faecal genome

Intervention Type GENETIC

Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.

Bipolar disorder,mixed

The group includes subjects who are diagnosed to mixed episode of bipolar disorder.

Faecal genome

Intervention Type GENETIC

Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.

First episode major depression

The group includes subjects who are diagnosed to first episode of major depression.

Faecal genome

Intervention Type GENETIC

Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.

major depression,recurrent

The group includes subjects who are diagnosed to recurrent episode of major depression.

Faecal genome

Intervention Type GENETIC

Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.

Healthy control

The group includes subjects who are Healthy control.

Faecal genome

Intervention Type GENETIC

Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Faecal genome

Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Conforms to the diagnosis of bipolar disorder or major depressive disorder.
* Take antibiotics continuously less than 3 days in recent 3 months.
* 17.5≦BMI≦30
* Age≦65

Exclusion Criteria

* who is diagnosed with physical diseases and other mental diseases.
* pregnant or lactational women
* who is diagnosed with mental retardation.
Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

First Affiliated Hospital Xi'an Jiaotong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiancang Ma, professor

Role: STUDY_DIRECTOR

First Affiliated Hospital Xi'an Jiaotong University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xiancang Ma

Xi'an, Shaanxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiancang Ma, professor

Role: CONTACT

13002951782

Wei Wang

Role: CONTACT

86-13991985805

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiancang Ma, professor

Role: primary

+8613002951782

Wei Wang, doctor

Role: backup

86-13991985805

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TGMOBAD2017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gut Microbiome and Depression
NCT05808101 TERMINATED